Healthcare technology company Observia, with academic support from Kingston University, has developed a groundbreaking patient profiling tool that demonstrates significant promise in predicting medication non-adherence risk among chronic disease patients.
Published in Nature Scientific Reports, the SPUR 6/24 tool addresses the critical healthcare challenge of treatment non-compliance, which affects approximately 50% of chronic disease patients and contributes to poor health outcomes and increased healthcare costs. The research validates a novel approach to identifying both non-adherence risk and the underlying psychological and social drivers behind patient decisions.
Study Design and Methodology
The research analyzed data from over 1,800 patients across five cohorts in three countries over four years, including individuals with type 2 diabetes, cardiovascular disease, and COPD.
The SPUR framework assesses non-adherence risk through 13 behavioral drivers categorized into four domains: Social, Psychological, Usage, and Rational. Researchers employed structural equation modeling to map interrelationships between drivers, enabling identification of causal relationships within the behavioral framework for the first time.
Key Findings and Behavioral Insights
The study revealed that while patients frequently cite practical reasons like forgetting doses (Usage) or doubting medication effectiveness (Rational) for non-adherence, deeper psychological and social factors exert powerful indirect influences:
Social identity and resistance to external direction significantly impact compliance behavior
Psychological reactance (resistance to being told what to do) leads patients to rationalize non-adherence with seemingly practical excuses
These underlying factors create a “nesting doll” effect where surface explanations mask deeper behavioral drivers
The tool demonstrated 85% accuracy in predicting non-adherence risk, substantially outperforming conventional assessment methods.
Clinical Applications and Intervention Strategies
“The SPUR 6/24 serves as a diagnostic map guiding healthcare professionals to the nested nature of patient behavior,” explained Dr. Josh Wells. By identifying root causes rather than surface explanations, clinicians can develop targeted interventions addressing the actual drivers of non-compliance.
For example, patients exhibiting psychological reactance might respond better to collaborative decision-making approaches rather than directive instructions, while social identity concerns might be addressed through peer support programs.
Technological Innovation and Implementation
The web-based platform enables efficient patient profiling during routine clinical encounters, generating personalized risk assessments and intervention recommendations. ”
This represents the first opportunity to systematically explore how different factors influence adherence behavior,” said Professor Kevin Dolgin, Observia co-founder. The tool’s quantitative approach moves beyond traditional subjective assessments to provide actionable insights for healthcare providers.
Implications for Chronic Disease Management
With chronic diseases accounting for approximately 75% of healthcare spending globally, the SPUR framework offers significant potential for improving outcomes and reducing costs.
The research demonstrates that addressing the psychological and social dimensions of non-adherence may be more effective than traditional educational approaches focused solely on practical barriers. Future applications could expand to mental health, oncology, and other therapeutic areas where treatment adherence critically impacts outcomes.
Related topics
